Artificial intelligence-driven biopharma company twoXAR Inc. has raised $10m via a series A financing, led by SoftBank Ventures, to grow and advance its in-house preclinical pipeline.
TwoXAR will launch between six and eight new internal development programs over the next year, but it has not yet...






